Oracle (ORCL) Stock Forecast & Price Target

Q: What analysts cover Oracle?

Oracle has been rated by research analysts at Argus , Barclays , BMO Capital Markets , Cantor Fitzgerald , Citigroup , Citizens Jmp , DA Davidson , DZ Bank , Freedom Broker , Guggenheim , Jefferies Financial Group , JPMorgan Chase & Co. , KeyCorp , Morgan Stanley , Oppenheimer , Royal Bank Of Canada , Sanford C. Bernstein , Scotiabank , Stephens , Stifel Nicolaus , TD Cowen , The Goldman Sachs Group , UBS Group , Weiss Ratings , and Yorkville Ives in the past 90 days.

$126.10 +0.56 (+0.45%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$126.13 +0.03 (+0.02%)

As of 10/23/2026 08:00 PM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 46 Analyst Ratings

Sell
1

Hold
9

Buy
36

Based on 46 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 46 analysts, 1 has given a sell rating, 9 have given a hold rating, 35 have given a buy rating, and 1 has given a strong buy rating for ORCL.

Consensus Price Target

$248.75
97.26% Upside

According to the 46 analysts' twelve-month price targets for Oracle, the average price target is $248.75. The highest price target for ORCL is $400.00, while the lowest price target for ORCL is $110.00. The average price target represents a forecasted upside of 97.26% from the current price of $126.10.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 10/25/25 to 10/25/26	1 Month Ago 9/25/25 to 9/25/26	3 Months Ago 7/27/25 to 7/27/26	1 Year Ago 10/25/24 to 10/25/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)
Buy	35 Buy rating(s)	36 Buy rating(s)	32 Buy rating(s)	24 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)	10 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$248.75	$251.72	$260.24	$326.64
Forecasted Upside	97.26% Upside	83.50% Upside	116.87% Upside	15.24% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Technology Companies	Broader Market
Consensus Rating Score	2.78	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	97.26% Upside	836.50% Upside	16.91% Upside
News Sentiment Rating	Positive News See Recent ORCL News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/23/2026	The Goldman Sachs Group 3 of 5 stars	Kash Rangan 1 of 5 stars	Lower Target	Buy	$240.00 ➝ $206.00	+64.34%
10/22/2026	Cantor Fitzgerald 5 of 5 stars	Thomas Blakey 2 of 5 stars	Reiterated Rating	Overweight	$284.00	+119.98%
10/16/2026	Weiss Ratings 3 of 5 stars		Reiterated Rating	Hold (C)
10/7/2026	Yorkville Ives Subscribe to MarketBeat All Access to unlock brokerage rankings	Dan Ives Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	In-Line	$155.00	+7.80%
10/2/2026	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Tyler Radke Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Market Outperform
10/2/2026	Citizens Jmp Subscribe to MarketBeat All Access to unlock brokerage rankings	Patrick Walravens Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Market Outperform	$285.00	+106.39%
9/25/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access to unlock brokerage rankings	Mark L. Moerdler Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy
9/17/2026	DZ Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Buy
9/14/2026	Freedom Broker Subscribe to MarketBeat All Access to unlock brokerage rankings	Egor Tolmachev Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$210.00 ➝ $205.00	+41.88%
9/14/2026	Argus Subscribe to MarketBeat All Access to unlock brokerage rankings	Joseph Bonner Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$225.00	+49.87%
Why Gerardo Del Real says wait before buying uranium stocks (Ad) Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare. Watch Gerardo Del Real's new uranium market breakdown now
9/11/2026	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Karl Keirstead Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$245.00 ➝ $250.00	+59.94%
9/11/2026	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Brad Reback Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$220.00 ➝ $200.00	+30.57%
9/11/2026	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Raimo Lenschow Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Overweight	$250.00 ➝ $252.00	+64.52%
9/11/2026	KeyCorp Subscribe to MarketBeat All Access to unlock brokerage rankings		Set Target		$285.00	+86.07%
9/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Rishi Jaluria Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Sector Perform	$190.00 ➝ $165.00	+5.53%
9/11/2026	DA Davidson Subscribe to MarketBeat All Access to unlock brokerage rankings	Gil Luria Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$225.00	+43.90%
9/11/2026	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings	Brett Huff Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Equal Weight	$175.00	+14.25%
9/11/2026	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Keith Bachman Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$220.00 ➝ $195.00	+27.31%
9/10/2026	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Brent Thill Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$320.00 ➝ $290.00	+118.64%
9/10/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Buy
9/9/2026	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Derrick Wood Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$300.00 ➝ $240.00	+48.39%
9/9/2026	Scotiabank Subscribe to MarketBeat All Access to unlock brokerage rankings	Patrick Colville Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Sector Outperform	$241.00 ➝ $215.00	+33.19%
9/8/2026	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	John DiFucci Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$375.00 ➝ $400.00	+152.13%
9/8/2026	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Brian Schwartz Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Outperform	$235.00 ➝ $275.00	+73.34%
9/4/2026	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Keith Weiss Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Equal Weight	$207.00 ➝ $210.00	+35.92%
7/20/2026	CLSA Subscribe to MarketBeat All Access to unlock brokerage rankings	Bhavtosh Vajpayee Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	Hold	$145.00	+14.64%
7/20/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Sell	$155.00 ➝ $110.00	-17.07%
7/14/2026	President Capital Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Overweight	$360.00 ➝ $300.00	+126.18%
6/15/2026	Phillip Securities Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Buy	$275.00 ➝ $237.00	+78.68%
6/12/2026	HSBC Subscribe to MarketBeat All Access to unlock brokerage rankings		Lower Target	Buy	$345.00 ➝ $316.00	+138.24%
6/12/2026	BNP Paribas Exane Subscribe to MarketBeat All Access to unlock brokerage rankings		Boost Target	Outperform	$283.00 ➝ $290.00	+118.64%
6/11/2026	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Daniel Ives Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$275.00 ➝ $240.00	+33.18%
6/11/2026	Wolfe Research Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Outperform	$275.00 ➝ $225.00	+11.92%
6/11/2026	Moffett Nathanson Subscribe to MarketBeat All Access to unlock brokerage rankings		Set Target		$325.00	+61.66%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Billy Fitzsimmons Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Overweight	$210.00 ➝ $225.00	+11.92%
6/10/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access to unlock brokerage rankings	Brad Zelnick Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$375.00 ➝ $300.00	+126.18%
6/9/2026	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Brad Sills Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$200.00 ➝ $240.00	+13.39%
6/8/2026	Evercore Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Outperform	$220.00 ➝ $245.00	+14.80%
6/5/2026	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	John Difucci Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$400.00	+69.12%
6/3/2026	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Siti Panigrahi Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target	Outperform	$400.00 ➝ $320.00	+30.72%
Cigar Lake Flooded Again Uranium Supply Shock Repeats (Ad) In 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This past May, flooding hit the same complex again, and in July Cigar Lake went down a second time, disrupting the world's largest high-grade uranium mine. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it. See the three companies positioned for uranium's next supply shock
5/7/2026	Arete Research Subscribe to MarketBeat All Access to unlock brokerage rankings		Set Target	Neutral ➝ Buy	$255.00	+31.31%
3/13/2026	Citic Securities Subscribe to MarketBeat All Access to unlock brokerage rankings		Upgrade	Hold ➝ Buy	$243.00 ➝ $200.00	+50.78%
3/11/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Neutral ➝ Hold
3/10/2026	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Rob Oliver Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$300.00 ➝ $200.00	+31.98%
2/9/2026	Melius Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Ben Reitzes Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target		$160.00	+2.82%
12/3/2025	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings		Initiated Coverage	Equal Weight ➝ Overweight	$280.00	+39.15%
11/10/2025	Erste Group Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		Downgrade	Buy ➝ Hold
10/20/2025	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Neutral
10/17/2025	William Blair Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Outperform
6/18/2025	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Hold
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Strong-Buy
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Curtis Shauger Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%
6/10/2025	Loop Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Mark Murphy Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target		$135.00	-23.99%
6/9/2025	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access to unlock brokerage rankings		Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:53 AM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, October 24, 2026. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle's stock is currently trading at $126.10, which is significantly below its 52-week high of $287.19, presenting a potential value opportunity for investors who believe the market has overreacted to recent volatility. This price point is also well below the average analyst price target of $251.72, suggesting substantial upside potential if the company continues to execute on its strategic initiatives.
The company recently reported strong financial performance, beating consensus estimates for both earnings per share and revenue in its latest quarter. Oracle reported $1.92 in earnings per share, exceeding the expected $1.74, and generated $19.34 billion in revenue, surpassing the forecast of $19.13 billion. This demonstrates the company's ability to deliver strong results and maintain its position as a leader in enterprise software and cloud services.
Oracle has secured significant new business opportunities, including a commitment from TikTok's U.S. operation to use Oracle Cloud Infrastructure as its primary provider for multiple gigawatts of computing capacity. This deal highlights the growing demand for Oracle's cloud services and positions the company to benefit from the expanding AI and data center market.
The company has announced a $1 billion investment in its partner ecosystem to support AI-driven modernization projects. This initiative aims to expand Oracle's reach and generate additional cloud demand, further solidifying its position in the competitive cloud services market and providing a long-term growth driver for the business.
Oracle's strong backlog of approximately $664 billion in future contracts provides a solid foundation for future revenue growth. This backlog, combined with the company's recent guidance for fiscal year 2027, indicates a stable and predictable revenue stream, which is attractive to investors seeking consistent performance.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Oracle is facing significant concerns over its heavy capital expenditures on AI data centers, which have led to negative free cash flow and elevated borrowing costs. Reports that Oracle's bond yields are approaching 9% have intensified fears that the company may need to rely on expensive debt or equity issuance to fund its AI growth, potentially diluting shareholder value.
The stock has experienced a substantial decline from its early June highs, with a 49.59% drop to recent levels. This sharp decline reflects investor concerns about the company's ability to manage its aggressive AI investment strategy and the associated financial risks, which could continue to weigh on the stock price.
Recent insider selling activity, including significant share sales by CEO Michael Sicilia and other executives, may signal a lack of confidence in the company's near-term prospects. While insider trades can be part of pre-arranged plans, the volume of selling could be interpreted as a negative signal by the market.
Oracle's high debt-to-equity ratio of 1.89 and the associated interest expenses could limit its financial flexibility. This leverage, combined with the company's heavy capital spending, may constrain its ability to invest in other growth areas or respond to market downturns, increasing financial risk for shareholders.
The competitive landscape in the cloud services and AI infrastructure market is intensifying, with rivals like Alibaba and other tech giants vying for market share. Oracle's ability to maintain its competitive edge and convert its large backlog into profitable revenue will be crucial, but the increasing competition could pressure margins and growth rates.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 46 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $248.75, with a high forecast of $400.00 and a low forecast of $110.00.

46 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There is currently 1 sell rating, 9 hold ratings, 35 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 97.26% based on their 12-month stock forecasts.

Oracle has been rated by research analysts at Argus, Barclays, BMO Capital Markets, Cantor Fitzgerald, Citigroup, Citizens Jmp, DA Davidson, DZ Bank, Freedom Broker, Guggenheim, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Oppenheimer, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Yorkville Ives in the past 90 days.

Analysts like Oracle more than other "technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

MarketBeat monitors more than a dozen sources for Oracle analyst ratings, with the most recent rating issued on 10/23/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target